- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | NewGenIVF Group Limited: NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts | 2 | GlobeNewswire (USA) | ||
| Di | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.12.25 | NewGenIVF shifts Ras Al Khaimah project to joint development structure | 1 | Investing.com | ||
| 12.12.25 | NewGenIVF Group Limited: NewGen to Exercise Option to Convert Ras Al Khaimah Joint Venture into Joint Development, Projected to Boost Profits from US$67 Million to US$123 Million | 1 | GlobeNewswire (USA) | ||
| 02.12.25 | NewGenIvf GAAP EPS of $96.76, revenue of $3.30M | 4 | Seeking Alpha | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 25.11.25 | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 10.11.25 | NewGenIVF Group Limited: NewGen Announces Up to US$2 Million Share Repurchase Program | 5 | GlobeNewswire (USA) | ||
| 07.11.25 | NewGenIvf Group Limited: Market Value Lower Than Cash Assets? It's Time to Reevaluate NIVF | 646 | JCN Newswire | HONG KONG, Nov 6, 2025 - (ACN Newswire) - Abstract: High-Quality Small-Cap Stocks Are Expected to Catch Up in GainsOn October 29 local time, the Federal Reserve launched its fifth interest rate cut... ► Artikel lesen | |
| 05.11.25 | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 05.11.25 | NewGenIVF Group Limited: NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets | 1 | GlobeNewswire (USA) | ||
| 31.10.25 | NewGenIVF Group Limited: NewGen Enters Into an Innovative Digital Assets Purchase Agreement with White Lion to Acquire up to 600,000 Solana Tokens Valued at Over $110 Million | 260 | GlobeNewswire (Europe) | BANGKOK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries... ► Artikel lesen | |
| 20.10.25 | NewGenIVF Group Limited: NewGen Announces Strategic Entry into Art Tokenization Market with $2 Million Private Collection Deal, Expandable to $200 Million | 282 | GlobeNewswire (Europe) | BANGKOK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries... ► Artikel lesen | |
| 10.10.25 | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 10.10.25 | NewGenIVF Group Limited: Zacks Small-Cap Research Initiates Coverage on NewGen | 1 | GlobeNewswire (USA) | ||
| 09.10.25 | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 08.10.25 | NewGenIVF Group Limited: NewGen Establishes New Joint Venture Dedicated to Real Estate Development in UAE | 3 | GlobeNewswire (USA) | ||
| 06.10.25 | NewGenIvf's acquired IP valued at $17.9 million, boosts NAV | 4 | Investing.com | ||
| 06.10.25 | NewGenIVF Group Limited: NewGen Reports Total Gain from IP Acquisition of $17.9 Million for FY 2025 | 170 | GlobeNewswire (Europe) | Valuation Report from Big Four Global Accounting Firm Sets Fair Value of Acquired IP at US$17.9 Million and Boosts NAV per share by about US$8.9 Acquisition Will Aid NewGen's Transition From IVF Services... ► Artikel lesen | |
| 16.09.25 | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 29.07.25 | NewGenIvf acquires Cytometry Tech to expand U.S. fertility services; shares up | 1 | Seeking Alpha |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAVMED | 11,970 | 0,00 % | Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? | ||
| SIEMENS HEALTHINEERS | 43,630 | -2,00 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Der Konzernchef sowie der Finanzvorstand hätten... ► Artikel lesen | |
| FRESENIUS | 47,640 | +1,10 % | Fresenius: Nach 5-Jahres-Hoch - Analysten weiter optimistisch | Der Trading-Tipp des Tages ist diesmal Fresenius. In diesem Jahr läuft es für die Aktie bisher sehr gut. Gestern erreichte das Papier sogar ein 5-Jahres-Hoch. Heute findet sich Fresenius zwar am DAX-Ende... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,630 | +1,81 % | DAX-Check LIVE: Aixtron, BASF, Bayer, Fresenius Medical Care, K+S, SAP, Schaeffler im Fokus | Nach sieben Rekordtagen in Folge haben am Mittwoch am deutschen Aktienmarkt die Verkäufer die Oberhand gewonnen. Der DAX schloss 0,5 Prozent tiefer bei 25.286 Punkten. Nach sieben Rekordtagen in Folge... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,200 | -0,73 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec vor Zahlen mit einem Kursziel von 50,55 Euro auf "Outperform" belassen. Das erste Quartal... ► Artikel lesen | |
| HEARTFLOW | 33,550 | -1,87 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,060 | 0,00 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| GENEDX | 100,04 | +0,36 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,450 | +0,28 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| PRIVIA HEALTH GROUP | 23,600 | +1,68 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| RXSIGHT | 9,950 | 0,00 % | Expert Outlook: RxSight Through The Eyes Of 5 Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,210 | +1,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,300 | 0,00 % | Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies List for First Time | ||
| PROCEPT BIOROBOTICS | 30,940 | +2,08 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 297,40 | -0,07 % | Judge Tosses Drug Pricing Conspiracy Case Against CVS, UnitedHealth, Evernorth |
Das Unternehmen NEWGENIVF GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,429 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.